Global Anti-Epileptic Drugs Markets 2016-2018 & 2022 - Cannabis Products Help Reduce Epileptic Seizures - ResearchAndMarkets.com

DUBLIN--()--The "Anti-Epileptic Drugs: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering.

Global anti-epileptic drugs manufacturing market growth outlook is positive with significant growth potential for anti-epileptic drugs. Emerging market growth, rising old age population, increasing incidences of accidents globally is driving the demand for anti-epileptic drugs. At the same time, there is mounting pressure on anti-epileptic drugs manufacturers to reduce costs, minimize side effects and improve drugs quality.

The market for anti-epileptic drugs is somewhat concentrated with a few large players dominating the market. Major players in the market are Pfizer Inc., UCB, GlaxoSmithKline plc, Sanofi, Eisai Co. and others. The highest growth is projected to come from third generation anti-epileptic drugs. Major factors included economic growth and technological advancements. The USA is the largest market in terms of value in the anti-epileptic drugs market.

The market is challenged by restraints such as stringent regulations, high research and development costs and rising trade protectionism.

Anti-Epileptic Drugs Market Customer Information

  • Dangers of Pharmaceutical Epilepsy Drug Not Known to Pregnant Women
  • Cannabis Products Help Reduce Epileptic Seizures
  • Performance of Epilepsy Drugs in Elderly Patients
  • Patients with Drug-Refractory Epilepsy Can Benefit from Reducing AED'S

Key Mergers and Acquisitions in the Anti-Epileptic Drugs Market

  • Pfizer Acquired Hospira, Inc.
  • Ferrer Pharma Acquired Alexza Pharmaceuticals
  • Zogenix Acquired Brabant Pharma
  • Sawai Pharmaceutical Acquired Upsher-Smith Laboratories

Key Topics Covered:

1 Introduction

2 Summary And Highlights

3 Anti-Epileptic Drugs Market Characteristics

4 Anti-Epileptic Drugs Market Size And Growth

5 Anti-Epileptic Drugs Market Trends And Strategies

6 Pestle Analysis

7 Anti-Epileptic Drugs Market Segmentation

8 Anti-Epileptic Drugs Market Regional And Country Analysis

9 Global Anti-Epileptic Drugs Market Comparison With Macro Economic Factors

10 Asia-Pacific Anti-Epileptic Drugs Market

11 Asia-Pacific Anti-Epileptic Drugs Market: Country Analysis

12 Western Europe Anti-Epileptic Drugs Market

13 Western Europe Anti-Epileptic Drugs Market: Country Analysis

14 Eastern Europe Anti-Epileptic Drugs Market

15 Eastern Europe Anti-Epileptic Drugs Market: Country Analysis

16 North America Anti-Epileptic Drugs Market

17 North America Anti-Epileptic Drugs Market: Country Analysis

18 South America Anti-Epileptic Drugs Market

19 South America Anti-Epileptic Drugs Market: Country Analysis

20 Middle East Anti-Epileptic Drugs Market

21 Africa Anti-Epileptic Drugs Market

22 Anti-Epileptic Drugs Market Customer Information

23 Anti-Epileptic Drugs Market Competitive Landscape

24 Key Mergers And Acquisitions In The Anti-Epileptic Drugs Market

25 Appendix

Companies Mentioned

  • Eisai Co., Ltd.
  • Glaxosmithkline Plc
  • Pfizer Inc.
  • Sanofi S.A.
  • UCB S.A.

For more information about this report visit https://www.researchandmarkets.com/research/93vfc8/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs